Enhancement imaginaries: exploring public understandings of pharmaceutical cognitive enhancing drugs

References

• BBC News (2018) What would happen if we all took smart drugs? By Zaria Gorvett 7 September 2018. http://www.bbc.com/capital/story/20180907-what-would-happen-if-we-all-took-smart-drugs (accessed 5 November 2018).
   Google Scholar
• Cherry, C., Hopfe, C., MacGillivray, B., & Pidgeon, N. (2017). Homes as machines: Exploring expert and public imaginaries of low carbon housing futures in the United Kingdom. Energy Research & Social Science, 23, 36–45. doi:10.1016/j.erss.2016.10.011
   Web of Science ®Google Scholar
• Conrad, P. (2007). The medicalization of society. Baltimore, MD: Johns Hopkins University Press.
   Google Scholar
• Conrad, P., & Potter, D. (2004). Human growth hormone and the temptations of biomedical enhancement. Sociology of Health & Illness, 26, 184–215. doi:10.1111/j.1467-9566.2004.00386.x
   PubMed Web of Science ®Google Scholar
• Coveney, C.M. (2011). Cognitive enhancement? Exploring modafinil use in social context. In Sociological reflections on the neurosciences (pp. 203–228). Bingley, UK: Emerald Group Publishing Limited.
   Google Scholar
• Dodou, K., & Nazar, H. (2019). Cognitive enhancers: what they are, how they work and what is in the pipeline. Suicide, 14, 20.
   Google Scholar
• De Vries, R., Turner, L., Orfili, K., Bosk, C. (Eds.). (2007). The view from here: Bioethics and the social sciences. Oxford, UK: Blackwell.
   Google Scholar
• EMA. (2010). European Medicines Agency recommends restricting the use of modafinil Press Release, 22nd July EMA/459173/2010.
   Google Scholar
• Erler, A. (2017). The limits of the treatment-enhancement distinction as a guide to public policy. Bioethics, 31, 608–615. doi:10.1111/bioe.12377
   PubMed Web of Science ®Google Scholar
• Gabe, J., Coveney, C. M., & Williams, S. J. (2016). Prescriptions and proscriptions: moralising sleep medicines. Sociology of health & illness, 38(4), 627–644.
   Google Scholar
• Greely, H., Sahakian, B., Harris, J., Kessler, R.C., Gazzaniga, M., Campbell, P., & Farah, M.J. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456, 702. doi:10.1038/456702a
   PubMed Web of Science ®Google Scholar
• Harris, J. (2011) Enhancing evolution. New Jersey: Princeton University Press. doi:10.1086/ahr/46.2.418
   Google Scholar
• HM Government. (2017). 2017 Drug Strategy. July 2017. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/628148/Drug_strategy_2017.PDF. Accessed: March 2018.
   Google Scholar
• Jansen, N. (2017). Effects of Methylphenidate on Memory and Attention in Healthy Adults. Maastricht Student Journal of Psychology and Neuroscience, 6(1).
   Google Scholar
• Ketchum, F.B. (2013). Rethinking “cognitive” enhancement: The ethical stakes of user perspectives. AJOB Neuroscience, 4, 26–27. doi:10.1080/21507740.2012.748705
   Google Scholar
• Kitzinger, J. (1994). The methodology of focus groups: The importance of interaction between research participants. Sociology of Health & Illness, 16, 103–121. doi:10.1111/1467-9566.ep11347023
   Web of Science ®Google Scholar
• LeClair, A., Kelly, B.C., Pawson, M., Wells, B.E., & Parsons, J.T. (2015). Motivations for prescription drug misuse among young adults: Considering social and developmental contexts. Drugs: Education, Prevention and Policy, 22, 208–216.
   Web of Science ®Google Scholar
• Lopes, N., Clamote, T., Raposo, H., Pegado, E., & Rodrigues, C. (2015). Medications, youth therapeutic cultures and performance consumptions: A sociological approach. Health, 19, 430–448. doi:10.1177/1363459314554317
   PubMed Web of Science ®Google Scholar
• Lipinska, V., & Fuller, S. (2014) The proactionary imperative: A foundation for transhumanism. Basingstoke: Palgrave.
   Google Scholar
• Martin, P.A., Pickersgill, M., Coveney, C., & Williams, S. (2011). Pharmaceutical cognitive enhancement: Interrogating the ethics, addressing the issues. In Augmenting Cognition, (pp. 179–192). EPFL Press.
   Google Scholar
• MHRA. (2014). https://www.gov.uk/government/news/medicines-watchdog-makes-record-seizure-of-experimental-smart-drugs. Accessed 17 February 2018.
   Google Scholar
• Muller, U., Rowe, J.B., Rittman, T., Lewis, C., Robbins, T.W., & Sahakian, B.J. (2013). Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology, 64, 490–495. doi:10.1016/j.neuropharm.2012.07.009
   PubMed Web of Science ®Google Scholar
• National Union of Students (NUS). (2018). Taking the hit. Student drug use and how institutions respond. London: NUS.
   Google Scholar
• Outram, S.M. (2011). Cognitive enhancement: How questionable assumptions can shape science policy making. International Journal of Science in Society, 2, 41–50. doi:10.18848/1836-6236/cgp/v02i01/51520
   Google Scholar
• Petersen, M.A., Nørgaard, L.S., & Traulsen, J.M. (2015). Pursuing pleasures of productivity: university students’ use of prescription stimulants for enhancement and the moral uncertainty of making work fun. Culture, Medicine, and Psychiatry, 39, 665–679.
   PubMed Web of Science ®Google Scholar
• Pickersgill, M., & Hogle, L. (2015). Enhancement, ethics and society: Towards an empirical research agenda for the medical humanities and social sciences. Medical Humanities, 41, 136–142. doi:10.1136/medhum-2015-010718
   PubMed Web of Science ®Google Scholar
• Racine, E., & Forlini, C. (2010). Cognitive enhancement, lifestyle choice or misuse of prescription drugs? Neuroethics, 3, 1–4. doi:10.1007/s12152-008-9023-7
   Web of Science ®Google Scholar
• Ragan, C.I., Bard, I., & Singh, I. (2013). What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology, 64, 588–595. doi:10.1016/j.neuropharm.2012.06.016
   PubMed Web of Science ®Google Scholar
• Rose, N. (2009). The politics of life itself: Biomedicine, power, and subjectivity in the twenty-first century. Princeton, NJ: Princeton University Press.
   Google Scholar
• Sattler, S., Mehlkop, G., Graeff, P., & Sauer, C. (2014). Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: The influence of drug characteristics, social environment, and personal characteristics. Substance Abuse Treatment, Prevention, and Policy, 9, 8. doi:10.1186/1747-597x-9-8
   PubMed Web of Science ®Google Scholar
• Schelle, K. J., Olthof, B. M., Reintjes, W., Bundt, C., Gusman-Vermeer, J., & van Mil, A. C. (2015). A survey of substance use for cognitive enhancement by university students in the Netherlands. Frontiers in Systems Neuroscience, 9, 10.
   Google Scholar
• Steger, M. (2014) Market globalism in Steger, M., Battersby, P., & Siracusa, J. (Eds.). The Sage handbook of globalization (pp. 23–38). London, UK: Sage.
   Google Scholar
• Sugden, C., Housden, C.R., Aggarwal, R., Sahakian, B.J., & Darzi, A. (2012). Effect of pharmacological enhancement on the cognitive and clinical psychomotor performance of sleep-deprived doctors: A randomized controlled trial. Annals of Surgery, 255, 222–227. doi:10.1097/SLA.0b013e3182306c99
   PubMed Web of Science ®Google Scholar
• Taylor, C. (2004). Modern social imaginaries. Durham, NC: Duke University Press.
   Google Scholar
• The Telegraph (2018) ‘Smart drugs’ epidemic as one in 12 adults admit taking them - with most trying them at work. David Urban, Kimberley Rowell and Tracey Kiryango. 16 June 2018. https://www.telegraph.co.uk/news/2018/06/15/smart-drug-epidemic-one-12-adults-admit-taking-trying-work/ (accessed 5 November 2018).
   Google Scholar
• The Tab (2014) 1 in 5 students have used modafinil: study drug survey results. https://thetab.com/2014/05/08/1-in-5-students-have-used-modafinil-study-drug-survey-results-14102 (accessed 5 November 2018)
   Google Scholar
• Vrecko, S. (2013). Just how cognitive is “Cognitive Enhancement?” On the significance of emotions in university students' experiences with study drugs. AJOB Neuroscience, 4, 4–12. doi:10.1080/21507740.2012.740141
   PubMedGoogle Scholar
• Vrecko, S. (2015). Everyday drug diversions: A qualitative study of the illicit exchange and non-medical use of prescription stimulants on a university campus. Social Science & Medicine, 131, 297–304. doi:10.1016/j.socscimed.2014.10.016
   PubMed Web of Science ®Google Scholar
• Williams, S.J., Coveney, C.M., & Gabe, J. (2013). Medicalisation or customisation? Sleep, enterprise and enhancement in the 24/7 society. Social Science & Medicine, 79, 40–47. doi:10.1016/j.socscimed.2012.07.017
   PubMed Web of Science ®Google Scholar
• Williams, S.J., Martin, P., & Gabe, J. (2011). The pharmaceuticalisation of society? A framework for analysis. Sociology of Health & Illness, 33, 710–725. doi:10.1111/j.1467-9566.2011.01320.x
   PubMed Web of Science ®Google Scholar